Clinical bottom line
Current evidence supports that COVID-19 vaccination during pregnancy is safe and does not increase the risk of adverse maternal or fetal outcomes. Vaccination reduces the risk of severe COVID-19 infection in pregnant individuals, which itself is associated with increased complications. Studies also suggest potential benefits in reducing placenta-mediated complications and improving maternal mental health. These findings reinforce recommendations for COVID-19 vaccination as part of routine prenatal care to optimize maternal-fetal health (Piekos et al., 2022; Ghesquiere et al., 2024).
What the evidence shows
Piekos et al. (2022) analyzed maternal-fetal outcomes in the context of SARS-CoV-2 infection and COVID-19 vaccination, finding no association between vaccination and increased risk of preterm birth, stillbirth, or small-for-gestational-age infants. Conversely, maternal infection was linked to higher rates of adverse outcomes, underscoring vaccination’s protective role.
The COVIGRO study by Ghesquiere et al. (2024) reported that vaccinated pregnant individuals had lower incidence of placenta-mediated complications such as preeclampsia and fetal growth restriction compared to unvaccinated counterparts, suggesting a potential benefit beyond infection prevention.
Abdul-Rasul et al. (2026) conducted a prospective cohort study in Iraq confirming no significant differences in rates of miscarriage, preterm delivery, or neonatal intensive care admission between vaccinated and unvaccinated pregnant women.
Sami et al. (2024) explored maternal mental health outcomes, finding that vaccination was associated with reduced anxiety and depressive symptoms during pregnancy and postpartum, likely reflecting decreased COVID-19-related stress.
Collectively, these studies support the safety and multifaceted benefits of COVID-19 vaccination in pregnancy.
Caveats and uncertainty
Most data derive from observational studies with inherent confounding factors; randomized controlled trials in pregnancy remain limited.
Long-term developmental outcomes in offspring require further follow-up.
Vaccine type, timing during pregnancy, and booster effects need more granular evaluation.
Regional differences in healthcare access and viral variants may influence generalizability.
Psychosocial benefits of vaccination may vary by cultural context and require broader study.
How this may change practice
Clinicians should proactively counsel pregnant patients on the safety and benefits of COVID-19 vaccination to improve uptake.
Vaccination should be integrated into standard prenatal care protocols alongside other preventive measures.
Monitoring for placenta-mediated complications may be optimized in vaccinated populations.
Mental health screening and support remain important adjuncts in comprehensive prenatal care.
Ongoing surveillance and research will refine guidance on timing and vaccine choice during pregnancy.